In the UK, around 98,000 people are living with bladder cancer and over 10,000 new cases are diagnosed every year with 5,000 deaths. In the EU, there are approximately 123,135 new cases and 40,252 deaths …

The European Commission aims to reduce the burden of cancer through the Joint Action CANCON (European Guide on Quality Improvement in Comprehensive Cancer Control), European Code Against Cancer and by heavily investing on research. Antoni …

Discussing the legislator’s role in beating bladder cancer, Daciana Octavia Sarbu MEP says a broader strategy including, emissions from road traffic and pesticide limits is equally important if we are to control risk factors for …

How should we define success in disease management and track the level of achievement in order to continuously improve the health care system to be functional and sustainable? Dr. Zenichi Ihara, Health Economics Manager, Commercial …

The most common cause of work-related deaths in the EU is cancer and bladder cancer was one of the first cancers to be linked to occupation. The European Commission recently proposed changes to the Carcinogens …

Bladder Cancer screening is currently not recommended in routine practice partly because of low overall incidence. However, Prof Morgan Roupret, Professor, Université Paris, believes that rational screening policies for smaller groups of people based on …

Several occupations have an elevated risk of bladder cancer. The highest risks occur in workers within tobacco manufacture, dye and rubber production, nurses, hairdressers and radiation workers. Prof James W.F. Catto, Professor of Urology at the …

Vicinium is currently being evaluated in a single arm, registrational phase 3 clinical trial in the USA and Canada in patients with high grade Non Muscle Invasive Bladder Cancer (NMIBC). Dr Gregory Adams, Chief Development …

Recognising the need for consolidated focus on bladder cancer patients’ needs, Roche supports an opportunity for broad collaboration engaging professional societies, nurses, patient organisations and various European institutions. Pablo Perez-Moreno, International Medical Director – Oncology …

‘At the present point, only about half of all MIBC patients are in a position to be fully cured of their cancer 5 years after diagnosis.’ Dr Anne E Kiltie, Associate Professor, Department of Oncology, …